Safety and Efficacy of up to 60 h of iv Istaroxime in Pre-Cardiogenic Shock Patients: Design of the SEISMiC Trial
The study results will contribute to our understanding of the role of istaroxime in pre-CS patients and potentially provide insight into the drug's haemodynamic effects and safety in this population.
Authors
- Agnieszka Tycińska (ORCID: https://orcid.org/0000-0001-7855-7261)
- Marianela Barros
- Piotr Gajewski (ORCID: https://orcid.org/0000-0001-6013-5167)
- Gaurav Gulati (ORCID: https://orcid.org/0000-0002-7701-0878)
- Maria Novosadova
- Carlos Guardia
- Marı́a Luz Dı́az (ORCID: https://orcid.org/0000-0002-3743-078X)
- Ovidiu Chioncel (ORCID: https://orcid.org/0000-0002-3197-3628)
- Gad Cotter (ORCID: https://orcid.org/0000-0002-9613-3339)
- Steven G. Simonson
- Jan Biegus (ORCID: https://orcid.org/0000-0001-9977-7722)
- Robert Zymliński (ORCID: https://orcid.org/0000-0003-1483-7381)
- Matteo Pagnesi (ORCID: https://orcid.org/0000-0002-9298-7871)
- Alexander Mebazaa
- Beth Davison
- Piotr Ponikowski
- Marco Metra
- Phillip Simmons
Institutions
- Délégation Paris 5 (FR)
- Tufts Medical Center (US)
- Medical University of Białystok (PL)
- Inserm (FR)
- Carol Davila University of Medicine and Pharmacy (RO)
- National and Kapodistrian University of Athens (GR)
- Université Paris Cité (FR)
- Wroclaw Medical University (PL)
- Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu" (RO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Intensive Care Society (GB)
- Surgical Specialties (Canada) (CA)
- Hôpital Lariboisière (FR)
- Windtree Therapeutics (United States) (US)
- Momentum Research (US)
- Estudios Clínicos Latinoamérica (AR)
- University General Hospital Attikon (GR)
- Instituto Cardiovascular de Rosario (AR)
- University of Brescia (IT)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1002/ehf2.15102
- Citations
- 8
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- Windtree Therapeutics